Novo Nordisk was the leader in the space until Eli Lilly launched tirzepatide. The Denmark-based pharmaceutical giant markets semaglutide, sold under famous brand names such as Ozempic and Wegovy. But …
2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026?
view original post